LoginRegister
    Parliamentary panel to now examine regulation, control of medical devicesParliamentary panel to now examine regulation, control of medical devices
    Johnson and Johnson wins EMA vote for depression drug SpravatoJohnson and Johnson wins EMA vote for depression drug Spravato
    Granules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptomsGranules India gets USFDA nod for Fexofenadine Hydrochloride tablets to treat allergy symptoms
    Sanofi pulls popular heartburn drug Zantac in US, CanadaSanofi pulls popular heartburn drug Zantac in US, Canada
    Landmark trial expected after opioid settlement talks failLandmark trial expected after opioid settlement talks fail
    Ultrasound Equipment now classified as DRUGS, under purview DCA: Gazette notificationUltrasound Equipment now classified as DRUGS, under purview DCA: Gazette notification
    AstraZeneca, Daiichi Trastuzumab deruxtecan gets USFDA priority review for treating breast cancerAstraZeneca, Daiichi Trastuzumab deruxtecan gets USFDA priority review for treating breast cancer
    Bristol Myers Squibb-Pfizer Alliance in collaboration with Fitbit to take on Apple WatchBristol Myers Squibb-Pfizer Alliance in collaboration with Fitbit to take on Apple Watch
    Novartis Jakavi meets primary endpoint in study of acute graft-versus-host diseaseNovartis Jakavi meets primary endpoint in study of acute graft-versus-host disease
    Boehringer Ingelheim enrolls patients in Phase 2 trial of cystic fibrosis treatmentBoehringer Ingelheim enrolls patients in Phase 2 trial of cystic fibrosis treatment
    Five drug firms, distributors offer to settle US opioid suits with USD 50 billion package: ReportFive drug firms, distributors offer to settle US opioid suits with USD 50 billion package: Report
    Health Ministry to bring all Medical Devices under CDSCO regulations, Invites commentsHealth Ministry to bring all Medical Devices under CDSCO regulations, Invites comments
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X